Aromatase inhibitor is named as a drug or biological intervention in 8 clinical trials in our China, USA and UK trial registers, 3 of which are recruiting. Lead sponsors include Fudan University (2), Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University (2) and Astellas Pharma Global Development, Inc. (1). Registered phases: Phase 3, Phase 1, Phase 2 and Observational. Conditions studied include Breast Cancer; Hot Flashes; Advanced Breast Cancer.
Registers list studies that are recruiting, about to open, active but closed to enrolment, or enrolling by invitation. The UK and USA registers cover industry-sponsored studies only. Trial titles and statuses are copied from the registry as published.
| Condition (as registered) | Trials |
|---|---|
| Breast Cancer | 6 |
| Hot Flashes | 1 |
| Advanced Breast Cancer | 1 |
| Metastatic Breast Cancer | 1 |
| Endometrial Cancer | 1 |
| Malignant Neoplasm of Breast | 1 |
| Advanced Solid Tumor | 1 |
| Hormone Receptor-Positive Breast Cancer | 1 |
| HER2 Low Breast Carcinoma | 1 |
| Early-Stage Breast Cancer | 1 |
| Lead sponsor | Trials |
|---|---|
| Fudan University | 2 |
| Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University | 2 |
| Astellas Pharma Global Development, Inc. | 1 |
| Eli Lilly and Company | 1 |
| Pfizer | 1 |
| BeOne Medicines | 1 |
| Register | Aromatase inhibitor trials |
|---|---|
| Clinical trials in China | 6 |
| Clinical trials in USA | 3 |
| Clinical trials in UK | 1 |
A trial with sites in more than one country appears in each of those registers.
Everything on this page is copied from public ClinicalTrials.gov registry records โ it is not written from memory, and nothing here describes how Aromatase inhibitor works or whether it is effective. Each trial links to its own record so you can check it yourself.
This page is built automatically: a daily sync job reads the registry records behind our country trial registers, collects every trial that lists Aromatase inhibitor (or a registered synonym) as a drug or biological intervention, and tabulates the registry fields directly. Placebos and generic comparators are excluded. There is no AI drafting and no per-compound editorial pass, and the page has not been clinically reviewed. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The ClinicalTrials.gov data on this page was last retrieved on 24 Sep 2026.